Tregs are primarily utilized as possible targets for suppressing the activation and differentiation of CD4+ helper T cells and CD8+ cytotoxic T cells, as well as for promoting reactivity to self and tumor-specific antigens [30, 31]. This evidence concerns the gene CD8A and neoplasm.